Believability of real-world evidence (RWE) for informed regulatory decisions

被引：0
|
作者：
Leclerc, Jacinthe [1 ]
Brodovicz, Kimberly G. [2 ]
Chang, Stephen [3 ]
Assimon, Magdalene M. [4 ]
Urushihara, Hisashi [5 ]
Girman, Cynthia J. [6 ]
机构：
[1] Univ Quebec Trois Rivieres, Trois Rivieres, PQ, Canada
[2] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[3] US FDA, Rockville, MD 20857 USA
[4] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[5] Keio Univ, Tokyo, Japan
[6] CERobs Consulting LLC, Chapel Hill, NC USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Real-world evidence and regulatory drug approval
    Michael J. Raphael
    Bishal Gyawali
    Christopher M. Booth
    Nature Reviews Clinical Oncology, 2020, 17 : 271 - 272
  • [22] Comment on "Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment": Is Real-World Evidence Real?
    Chen, Chian
    Hsiao, Chin-Fu
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (01): : 18 - 19
  • [23] Use of Real-World Evidence for Drug Regulatory Decisions in China: Current Status and Future Directions
    Li, Pei
    Wang, Su
    Chen, Yuwen
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (6) : 1167 - 1179
  • [24] Use of Real-World Evidence for Drug Regulatory Decisions in China: Current Status and Future Directions
    Pei Li
    Su Wang
    Yuwen Chen
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 1167 - 1179
  • [25] Real-world evidence for coverage decisions: opportunities and challenges
    Hampson, Grace
    Towse, Adrian
    Dreitlein, William B.
    Henshall, Chris
    Pearson, Steven D.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (12) : 1133 - 1143
  • [26] Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes
    Patorno, Elisabetta
    Schneeweiss, Sebastian
    Wang, Shirley V.
    DIABETES OBESITY & METABOLISM, 2020, 22 : 45 - 59
  • [27] RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design
    Andrew D. Xia
    Caroline P. Schaefer
    Agota Szende
    Elke Jahn
    Matthew J. Hirst
    Drugs - Real World Outcomes, 2019, 6 : 193 - 203
  • [28] A PRAGMATIC APPROACH TO DATA SOURCE SELECTION FOR USE IN REAL-WORLD EVIDENCE (RWE) GENERATION
    Lie, X.
    Ivanescu, C.
    Nijhuis, T.
    VALUE IN HEALTH, 2015, 18 (07) : A488 - A488
  • [29] ADAPTIVE LICENSING AND REAL WORLD EVIDENCE (RWE)
    Dang, D.
    Dang, A.
    Bn, V
    Hyderboini, R. K.
    Vsn, M.
    Chakrawarthy, M.
    VALUE IN HEALTH, 2018, 21 : S51 - S52
  • [30] PREVALENCE AND INCIDENCE ESTIMATIONS IN GERMAN AMNOG APPLICATIONS - THE ROLE OF REAL-WORLD EVIDENCE (RWE)
    Altevers, J.
    Borchert, K.
    Mittendorf, T.
    Braun, S.
    VALUE IN HEALTH, 2015, 18 (07) : A558 - A558
12345